Abstract
BackgroundTofacitinib is an oral JAK inhibitor that has been investigated for the treatment of ankylosing spondylitis (AS).ObjectivesTo investigate for the first time the effects of tofacitinib in adult patients (pts)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
